We estimated the lymphocyte subpopulations (T and B lymphocytes, T4 subset (helper/inducer) and T8 subset (cytotoxic/suppressor) lymphocytes) in heparinised blood using monoclonal mouse antihuman antibodies (Dakopatts Company, Denmark) 
The epidemiological and clinical characteristics of donovanosis in areas where it is endemic1 2 or nonendemic3 are now well documented. Its pathogenesis, however, remains largely unknown, and its prime location in the genital region is intriguing. Tissue responses are local initially, but histopathology does not yield information about its pathogenesis. This study was undertaken to elucidate some aspects of the immune response of people with donovanosis.
Patients and methods
We investigated 36 patients with donovanosis, comprising 27 with ulcerogranulomatous, seven with hypertrophic, and two with sclerotic variants. The diagnosis in each case was made on the basis of the clinical features3 and Giemsa stained tissue smears. Diagnoses were confirmed by the characteristic histopathology4 and by showing Donovan bodies in slow (overnight) Giemsa stained tissue sections. A thorough general physical examination was undertaken to exclude concomitant disease.
We estimated the lymphocyte subpopulations (T and B lymphocytes, T4 subset (helper/inducer) and T8 subset (cytotoxic/suppressor) lymphocytes) in heparinised blood using monoclonal mouse antihuman antibodies (Dakopatts Company, Denmark)
Address for correspondence/ Professor V N Sehgal, A/6 Panchwati, Delhi-I 10 033, India Accepted for publication 8 November 1986 in an indirect immunofluorescence method. 5 We estimated the total and differential leucocyte count in heparinised blood to obtain the percentage and absolute counts of rymphocytes.
We separated the lymphocytes from the heparinised blood by gradient centrifugation using Histopaque solution (Sigma) containing Ficoll Hypaque 400 (57 g/l) and sodium diatrizoate (90 g/1). 6 The viability of lymphocytes was checked with trypan blue, and more than 90% of the cells were viable. A final cell suspension of 1-10 x 109/l was obtained, and 100 gl of this suspension-was centrifuged for five minutes at 100 x g. The cell pellet was resuspended in Hank's balanced salt solution, and 50 gl of specific monoclonal antibody (at a dilution of 1/10) was added and incubated. The lymphocytes were then washed twice and the lymphocyte suspension was mixed with 30 gl fluorescein conjugated (rabbit) antimouse immunoglobulin (Dakopatts, Denmark, F-232) diluted 1/16. After being incubated at 4°C for 30 minutes, the suspension was washed twice with Hank's balanced salt solution. Evans blue dye (1/30 000) was used to counterstain. The cells were finally washed and resuspended in 10 gl washing medium and an equal volume of buffered glycerol. A drop of suspension was placed on a microslide, covered with a coverslip, and sealed with nail polish. The slide was examined under an epi-illumination fluorescent microscope with relevant excitation and barrier filters applied.
We counted a total of 100 lymphocytes as shown by apple green fluorescence. We estimated the lymphocyte subpopulation as a percentage of all lymphocytes. We then calculated the absolute value in each Lymphocyte subpopulations in donovanosis assessed by monoclonal antibodies and immunoglobulins case by multiplying the percentage by absolute lymphocyte counts.
We measured serum IgM, IgG, and IgA concentrations by radial immunodiffusion using limit diffusion in agar gel7 on "Tripartigen plates" (Hoechst Pharmaceuticals, Bombay, India). Undiluted sera were used to estimate IgA and IgM, whereas the sera were diluted 10 times with isotonic saline to measure IgG concentrations. Standard control serum provided by Hoechst Pharmaceuticals was used to calibrate immunoglobulin concentrations.
Student's t test was used for statistical evaluation.
Results Table 1 shows that patients with ulcerogranulomatous donovanosis of less than three months' duration had significantly (t = 2.4, p < 0.05) increased total leucocyte counts, whereas the difference was not significant in patients who had had the disease longer or had other variants of it.
In patients with the ulcerogranulomatous variant of shorter duration, the T cell count was significantly (t = 217, p < 0.02) increased (table 2) . Patients with the hypertrophic variant, however, had increases in T4 cells and decreases in T lymphocytes and T8 cells, but these differences from control values were not significant. 
